10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577 89. 589. Loke YK, Kwok CS, Singh S. Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observa- tional studies. BMJ. 2011;342:1309. 590. Woodcock J. Center for Drug Evaluation and Research. Decision on continued marketing of rosiglitazone (Avandia, Avandamet, Avandaryl) [Report NDA 021071]. 2010. Available at: http://www.fda. gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformation forPatientsandProviders/UCM226959.pdf. Accessed January 15, 2011. 591. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and deter- minants of coronary artery disease in juvenile-onset, insulindependent diabetes mellitus. Am J Cardiol. 1987;59:750 5. 592. Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23 000 patients with insulin-treated diabetes. Diabe- tologia. 2003;46:760 5. 593. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291 7. 594. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035 8. 595. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141 7. 596. Getz GS. Report on the workshop on diabetes and mechanisms of atherogenesis. September 17th and 18th, 1992, Bethesda, Maryland. Arterioscler Thromb. 1993;13:459 64. 597. Alderman EL, Corley SD, Fisher LD, et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Partic- ipating Investigators and Staff. J Am Coll Cardiol. 1993;22:1141 54. 598. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term inten- sified insulin treatment on the development of microvascular compli- cations of diabetes mellitus. N Engl J Med. 1993;329:304 9. 599. 